Study of GSK3511294 in Healthy Chinese Participants
NCT05140200 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-01-27
Summary
This single dose pharmacokinetic (PK) study aims to investigate the PK, safety, tolerability and immunogenicity of two dose levels of GSK3511294 administered subcutaneously in Chinese healthy participants
Conditions
Interventions
- BIOLOGICAL
-
GSK3511294
GSK3511294 will be administered.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-12-10
- Primary Completion
- 2022-12-23
- Completion
- 2022-12-23
Countries
- China
Study Locations
More Related Trials
-
The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics
NCT00453791 ·Status: TERMINATED ·Phase: PHASE1
-
Study of CM512 Injection in Subjects With Moderate-to-severe Asthma
NCT07011524 ·Status: RECRUITING ·Phase: PHASE2
-
A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers
NCT00411814 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics
NCT04585009 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma
NCT00380354 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate GSK2190915 in Subjects With Mild Asthma
NCT00812773 ·Status: COMPLETED ·Phase: PHASE2
-
Repeat Dose Safety Study for Compound to Treat Asthma
NCT01202214 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, and Pharmacokinetics of QAW039
NCT01253603 ·Status: COMPLETED ·Phase: PHASE2
-
A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.
NCT01160003 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.
NCT00603382 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma
NCT06637254 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world Study
NCT06851403 ·Status: ENROLLING_BY_INVITATION
-
Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
NCT04719832 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Mild Asthmatic Patients
NCT00748306 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
NCT00603746 ·Status: COMPLETED ·Phase: PHASE2
-
Single Dose Study of GSK1440115 in Patients With Asthma
NCT01424280 ·Status: COMPLETED ·Phase: PHASE1
-
The Severity of Newly Diagnosed Asthma Patients and the Result of Initial 12 Weeks Treatment in China
NCT02143739 ·Status: COMPLETED
-
Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients
NCT00358488 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
NCT04718103 ·Status: COMPLETED ·Phase: PHASE3
-
A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®
NCT00532922 ·Status: COMPLETED
-
Efficacy and Safety Study in Subjects With Asthma
NCT00980200 ·Status: COMPLETED ·Phase: PHASE2
-
GSK2190915 Moderate to Severe Asthma Study
NCT00850642 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
NCT01269437 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
NCT01498653 ·Status: COMPLETED ·Phase: PHASE3
-
A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
NCT06419413 ·Status: RECRUITING